Latest

Longevity Medicine News

Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.

All ATMP clinical trials epigenetics Europe industry market NAD+ regenerative medicine regulation stem cells trends wellness economy

05 March 2026 Nature Aging Peer-reviewed

NAD+ Therapy Shows Measurable Epigenetic Age Reversal in New Clinical Trial

A 12-week randomised controlled trial finds IV NAD+ supplementation reduces biological age markers by an average of 2.4 years, with sustained effects at 6-month follow-up. Longevity clinics offering NAD+ protocols are already citing the data.

NAD+ clinical trials epigenetics

18 February 2026 European Medicines Agency Peer-reviewed

EU Tightens Stem Cell Therapy Regulations — What It Means for Longevity Clinics

The EMA's updated Advanced Therapy Medicinal Products framework introduces stricter traceability and manufacturing standards for stem cell treatments. European longevity clinics face a 12-month adaptation window.

stem cells regulation Europe

03 February 2026 Global Wellness Institute

The Longevity Clinic Market Reaches $28B — And Premium Positioning Is Driving Growth

The Global Wellness Institute's 2026 Longevity Economy Report values the longevity clinic market at $28 billion globally, up 34% from 2024. High-conviction clients, longer stays, and multi-program loyalty are reshaping how clinics compete.

market industry trends